CHERUB collaborative clinical trials

RIO

Viral suppression off antiretroviral therapy (ART) using dual broadly neutralising antibody (bNAb) therapy

Targeting the HIV ‘reservoir’ could be the first step to understanding how to cure the infection

The immunogenicity of Shingrix vaccination in HIV infected groups at risk of shingles infection (SAGE)

Soluble T-cell receptor intervention towards viral eradication

HIV Eradication through Early Antiretroviral Therapy

Immunotherapy cells as a HIV Cure Intervention

Prospective Interruption of Therapy towards a Cure for HIV

bNAbs in treatment naïve HIV-1 patients initiaiting ART